136 results on '"Hattori, Takamitsu"'
Search Results
2. Molecular basis for antibody recognition of multiple drug–peptide/MHC complexes
3. Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
4. Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
5. Selective and noncovalent targeting of RAS mutants for inhibition and degradation
6. The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability
7. Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors
8. High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification
9. Abstract B020: Creating actionable neoantigens by design with KRAS(G12C) covalent inhibitors
10. Abstract B013: Exploring the switch II pocket of KRAS(G12D) with mutant-selective monobody inhibitors
11. In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1-mutant lung cancer
12. Data from Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
13. Supplementary Figures 1-7 from Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
14. Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation
15. TMET-19. DEFINING A NOVEL ROLE FOR CD97 IN REGULATING GBM GLYCOLYTIC METABOLISM
16. Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
17. Epigenetic dysregulation by nickel through repressive chromatin domain disruption
18. Generation of camelid VHH bispecific constructs via in-cell intein-mediated protein trans-splicing
19. High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia
20. STEM-09. DEFINING THE ROLE OF CD97 IN GLIOBLASTOMA STEM CELL SELF-RENEWAL
21. Re-evaluating the role of nucleosomal bivalency in early development
22. Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
23. Abstract 1827: Efficacy and characterization of a specific and potent monoclonal antibody, LYT-210, against immunosuppressive gd1 T cell in cancer
24. Nanoparticles with affinity for biopolymer: Bioassisted room-temperature selective multistacking of inorganic particles on biopolymer film
25. Multiplex bead binding assays using off-the-shelf components and common flow cytometers
26. The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition
27. The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
28. SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling
29. High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization
30. Association behavior and control of the quality of cancer therapeutic bispecific diabodies expressed in Escherichia coli
31. Identification of Indium Tin Oxide Nanoparticle-Binding Peptides via Phage Display and Biopanning Under Various Buffer Conditions
32. SHP2 Inhibition Abrogates Adaptive Resistance to KRASG12C-Inhibition and Remodels the Tumor Microenvironment of KRAS-Mutant Tumors
33. Protein-protein interactions and selection: generation of molecule-binding proteins on the basis of tertiary structural information
34. Abstract 2382: Development and testing of the first in class immunotherapy targeting immuno-suppressive δ1 containing γδ T cells for the treatment of pancreatic ductal adenocarcinoma and other solid tumors
35. Complementary Design for Pairing between Two Types of Nanoparticles Mediated by a Bispecific Antibody: Bottom-Up Formation of Porous Materials from Nanoparticles
36. Next-generation antibodies for post-translational modifications
37. Compact Seahorse‐Shaped T Cell–Activating Antibody for Cancer Therapy
38. Impact in stability during sequential CDR grafting to construct camelid VHH antibodies against zinc oxide and gold
39. Mechanism of disease and therapeutic rescue of Dok7congenital myasthenia
40. Direct and selective immobilization of proteins by means of an inorganic material-binding peptide: discussion on functionalization in the elongation to material-binding peptide
41. Identification of Indium Tin Oxide Nanoparticle-Binding Peptides viaPhage Display and Biopanning Under Various Buffer Conditions
42. What factors influence chemical conjugation reactions on small antibody?
43. Highly Specific Recognition of Histone Post-translational Modifications by Antigen-clasping Antibodies
44. Direct Measurement of Radioactive Carbon in Vietnamese Vodkas by Liquid Scintillation Counter
45. Application of 300× Enhanced Fluorescence on a Plasmonic Chip Modified with a Bispecific Antibody to a Sensitive Immunosensor
46. Recombinant antibodies to histone post-translational modifications
47. Broad Ranges of Affinity and Specificity of Anti-Histone Antibodies Revealed by a Quantitative Peptide Immunoprecipitation Assay
48. A High-Affinity Gold-Binding Camel Antibody: Antibody Engineering for One-Pot Functionalization of Gold Nanoparticles as Biointerface Molecules
49. Zinc Oxide-Coated Plasmonic Chip Modified with a Bispecific Antibody for Sensitive Detection of a Fluorescent Labeled-Antigen
50. High Affinity Anti-inorganic Material Antibody Generation by Integrating Graft and Evolution Technologies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.